See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Paul Naaber

https://www.etis.ee/CV/Paul_Naaber/est
7.12.1966
paul.naaber@ut.ee

Teenistuskäik

Töökohad ja ametid
01.01.2021–...   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise mikrobioloogia kaasprofessor (0,25)
01.01.2013–...   
SYNLAB Eesti OÜ, Infektsioonhaiguste valdkonna juht (1,00)
01.10.2020–31.12.2020   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise mikrobioloogia vanemteadur (0,25)
01.10.2019–30.09.2020   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise mikrobioloogia vanemteadur (0,35)
01.01.2018–30.09.2019   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise mikrobioloogia vanemteadur (0,10)
01.01.2016–31.12.2017   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise mikrobioloogia vanemteadur (0,10)
01.01.2015–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilise mikrobioloogia vanemteadur (0,50)
01.12.2011–31.12.2014   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilise mikrobioloogia vanemteadur (0,50)
01.01.2010–30.11.2011   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilise mikrobioloogia vanemteadur (0,20)
01.12.2007–31.12.2009   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, mikrobioloogia vanemteadur (0,20)
01.01.2006–31.12.2012   
Stavangeri Ülikoooli Haigla, konsultant mikrobioloog
01.01.2005–30.11.2007   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, mikrobioloogia vanemteadur (0,30)
01.01.2005–31.12.2005   
Sotsiaalministeerium, Rahvatervise osakond, nakkushaiguste peaspetsialist
01.01.2001–31.12.2004   
SA TÜK Ühendlabori direktori kt.
1998–2006   
SA Tartu Ülikooli Kliinikum, osakonnajuhataja (1,00)
01.01.1998–31.12.2005   
TÜ mikrobioloogia instituudi vanemteadur
01.01.1996–31.12.1998   
TÜ mikrobioloogia instituudi assistent
01.01.1996–31.12.1997   
TÜ mikrobioloogia instituudi vanemlaborant
01.01.1995–31.12.1998   
Berner Eesti AS, laborikaupade müügijuht
01.01.1992–31.12.1997   
Maarjamõisa haigla mikrobioloogia labori/TÜK Ühendlabori mikrobioloogia osakonna laboriarst
01.01.1991–31.12.1992   
TÜ Nakkushaiguste kateedri stazöör-uurija
 
 
Haridustee
1999–2001   
TÜ Avatud Ülikool filosoofia eriala (läbinud alg- ja keskastme)
1998–2000   
TÜ mikrobioloogia instituut, järeldoktorantuur
1992–1997   
TÜ, doktorantuur infektsioonhaiguste ja mikrobioloogia erialal
1985–1991   
TÜ arstiteaduskond ravi eriala
1982–1985   
Tallinna 2. Keskkool

Kvalifikatsioon

Teaduskraadid
Paul Naaber, doktorikraad, 1997, (juh) Marika Mikelsaar; Matti Maimets, Clostridium difficile infection and intestinal microbial ecology (Clostridium difficile infektsioon ja seedetrakti mikroobiökoloogia), Tartu Ülikool, Arstiteaduskond.
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.2. Mikrobioloogia; CERCS KLASSIFIKAATOR: B230 Mikrobioloogia, bakterioloogia, viroloogia, mükoloogia ; TÄPSUSTUS: kliiniline mikrobioloogia, antimikroobne resitentsus, mikroobi ökoloogia

Jooksvad projektid

Lõppenud projektid

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2020
Naaber, Paul; Hunt, Kaidi; Pesukova, Jaana; Haljasmägi, Liis; Rumm, Pauliina; Peterson, Pärt; Hololejenko, Jelena; Eero, Irina; Jõgi, Piia; Toompere, Karolin; Sepp, Epp (2020). Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. PLoS ONE, 15 (10), e0237548. DOI: 10.1371/journal.pone.0237548.
5.2.
2020
Piia Jõgi1,2, Diana Ingerainen3, Mari Soots4, Freddy Lättekivi5,6,7, Paul Naaber8,9, Karolin Toompere10, Hannes Vaas1, Pärt Peterson11, Katrin Kaarna6,7, Heli Paluste12, Kai Kisand11, Marje Oona13, Riina Janno6,7, Irja Lutsar8 (2020). Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1). ESCMID Conference on Coronavirus Disease (ECCVID), virtual 23-25.09.2020. ESCMID.
6.8.
2020
Veerus, Piret; Salumets, Andres; Naaber, Paul; Krjutškov, Kaarel; Tilk, Kadi; Laanpere, Made; Uusküla, Anneli (2020). Seroprevalence of SARS-CoV-2 antibodies among pregnant women in Estonia: A call for epidemiological studies. Acta Obstetricia Et Gynecologica Scandinavica, 1736−1737. DOI: 10.1111/aogs.13995.
1.1.
2019
Bilozor, Anastasia; Balode, Arta; Chakhunashvili, Giorgi; Chumachenko, Tetyana; Egorova, Svetlana; Ivanova, Marina; Kaftyreva, Liidia; Kõljalg, Siiri; Kõressaar, Triinu; Lysenko, Olga; Miciuleviciene, Jolanta; Mändar, Reet; Lis, Danuta O.; Wesolowska, Monika Pomorska; Ratnik, Kaspar; Remm, Maido; Rudzko, Jelena; Rööp, Tiiu; Saule, Mara; Sepp, Epp ... Naaber, Paul (2019). Application of Molecular Methods for Carbapenemase Detection. Frontiers in Microbiology, 10, ARTN 1755. DOI: 10.3389/fmicb.2019.01755.
1.1.
2019
Sepp, Epp; Andreson, Reidar; Balode, Arta; Bilozor, Anastasia; Brauer, Age; Egorova, Svetlana; Huik, Kristi; Ivanova, Marina; Kaftyreva, Lidia; Kõljalg, Siiri; Koressaar, Triinu; Makarova, Maria; Miciuleviciene, Jolanta; Pai, Kristiine; Remm, Maido; Rööp, Tiiu; Naaber, Paul (2019). Phenotypic and Molecular Epidemiology of ESBL-, AmpC-, and Carbapenemase-Producing Escherichia coli in Northern and Eastern Europe. Frontiers in Microbiology, 10, ARTN 2465. DOI: 10.3389/fmicb.2019.02465.
1.3.
2019
Mikelsaar, Marika; Lõivukene, Krista; Naaber, Paul; Mändar, Reet (2019). Helicobacter pyllori infektsioonide teaduspõhine diagnostika ja mikroobivastane ravi. Eesti Arst, 98 (7), 381−384.
5.2.
2018
Naaber, Paul; Rudzko, Jelena; Pavelkovich, Anastasia; Ivanova, Marina; Sepp, Epp; Ratnik, Kaspar; Kõljalg, Siiri; Rööp, Tiiu; Remm, Maido; Kaftyreva, Liidia; Egorova, Svetlana; Miciuleviciene, Jolanta; Balode, Arta; Saule, Marta; Tsereteli, David; Chakhunashvili, Giorgi; Titiv, Leonid; Shyshporonok, Julia; Lysenko, Olga; Chumachenko, Tatyana ... Wesolowska, Monika (2018). Comparison of Coris rapid test with other methods for carbapenemases detectiotion in Klebsiella pneumoniae. In: (60).35h annual meeting NSCMID, Reykjavik 19-22 august. Reykjavik, Island.
1.1.
2017
Roosaare, Märt; Vaher, Mihkel; Kaplinski, Lauris; Möls, Märt; Andreson, Reidar; Lepamets, Maarja; Kõressaar, Triinu; Naaber, Paul; Kõljalg, Siiri; Remm, Maido (2017). StrainSeeker: fast identification of bacterial strains from raw sequencing reads using user-provided guide trees. PeerJ, 5, ARTN e3353−e3353.10.7717/peerj.3353.
1.1.
2017
Rätsep M.; Kõljalg S.; Sepp E.; Smidt I.; Truusalu K.; Songisepp E.; Stsepetova J.; Naaber P.; Mikelsaar R.H.; Mikelsaar M. (2017). A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection. Anaerobe, 47, 94−103.10.1016/j.anaerobe.2017.03.019.
5.2.
2016
Pavelkovich, A.; Naaber, P.; Ivanova, M.; Sepp, E.; Rööp, T.; Plaas, K.; Kaftyreva, L.; Egorova, S.; Miciuleviciene, J.; Balode, A.; Saule, M.; Tsereteli, D.; Chakhunashvili, G.; Lysenko, O.; Chumachenko, T.; Wesolowska, M.; Lis, D.; Titov, L.; Shyshporonok, J. (2016).

Karbapeneemiresistentsuse uurimine Enterobacteriaceae, Pseudomonas aeruginosa ja Acinetobacter spp. tüvedel 9 Euroopa riigis

. Eesti Arst, 95 (lisa 2): Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2016; Tartu; 13.-14.10.2016. Celsius Healthcare OÜ, 33−33.
5.2.
2016
Pavelkovich, A.; Ivanova, M.; Kõljalg, S.; Naaber, P.; Pai, K.; Sepp, E.; BEEp research team (2016). Epidemiology of AB resistant gram-negative bacteria in the Baltic Sea region. Eesti Arst, 95 (Supplement1): XIII Baltic Congress in Laboratory Medicine; Tartu, Estonia; May 12-14 2016. OÜ Celsius Healthcare, 39.
1.3.
2015
Ivanova, M.; Pavelkovich, A.; Naaber, P. (2015). Ida-Tallinna Keskhaigla mikrobioloogia labori rahvusvaheline koostöö. Eesti Arst, 94 (4), 9−11.
1.1.
2014
Pavelkovich, Anastasia; Balode, Arta; Edquist, Petra; Egorova, Svetlana; Ivanova, Marina; Kaftyreva, Lidia; Konovalenko, Irina; Kõljalg, Siiri; Lillo, Jana; Lipskaya, Lidia; Miciuleviciene, Jolanta; Pai, Kristiine; Parv, Kristel; Pärna, Katri; Rööp, Tiiu; Sepp, Epp; Štšepetova, Jelena; Naaber, Paul (2014). Detection of Carbapenemase-Producing Enterobacteriaceae in the Baltic Countries and St. Petersburg Area. BioMed Research International, 2014, Article 548960.10.1155/2014/548960.
1.1.
2014
Mitt, P.; Metsvaht, T.; Adamson, V.; Telling, K..; Naaber, P.; Lutsar, I.; Maimets , M. (2014). Five-year prospective surveillance of nosocomial bloodstream infections in an Estonian paediatric intensive care unit. Journal of Hospital Infection, 86 (2), 95−99.10.1016/j.jhin.2013.11.002.
1.3.
2013
Егорова, СА; Кафтыреща, ЛА; Липская, ЛВ; Коноваленко, ИБ; Пясетская, МФ; Курчикова, ТС; Ведерникова, НБ; Морозова, ОТ; Смирнова, МБ; Попенко, ЛН; Любушкина, МИ; Савочкина, ЮА; Макарова, МА; Сужаева, ЛВ; Останкова, ЮВ; Иванова, МН; Павелкович, АМ; Наабер, П; Сепп, Э; Кыльялг, С ... Балоде, А. (2013). Штаммы энтеробактерий, продуцирующие бета-лактамазы пасширенного спектра и металло-В-лактамазу НДМ-1, выделенные в стационарах в странах Балтийского региона. Инфекция и иммунитет, 3 (1), 29−36.
5.2.
2013
Rätsep, Merle; Naaber, Paul; Kõljalg, Siiri; Smidt, Imbi; Shkut, Leena; Sepp, Epp (2013). Antagonistic activity of culture supernatant of lactobacilli against the growth of Clostridium difficile in vitro. ClostPath 2013 Meeting; Palm Cove, Australia; 22.-26. October 2013.
5.2.
2013
Pavelkovich, A; Balode, A; Edquist, P; Egorova, S; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Lipskaya, L; Miciuleviciene, J; Pai, K; Sepp, E; Sparbier, K; Naaber, P (2013). Detection of carbapenem-non-susceptible Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013..
5.2.
2013
Lillo, J; Balode, A; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Makarova, M; Miciuleviciene, J; Naaber, P; Pai, K; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). Differences in virulence factors of Escherichia coli isolated from the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Naaber, P; Balode, A; Djundika, T; Egorova, S; Huik, K; Kaftyreva, L; Kamõnina, N; Kirs, K; Kõljalg, S; Konovalenko, I; Kurchikova, T; Lillo, J; Lipskaya, L; Lõivukene, L; Makarova, M; Makstutis, G; Miciuleviciene, J; Morozova, O; Pai, K; Parv, K ... Ivanova, M (2013). Epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Pai, K; Balode, B; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Miciuleviciene, J; Naaber, P; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). The molecular epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
1.1.
2012
Adamson, V.; Mitt, P.; Pisarev, H.; Metsvaht, T.; Telling, K.; Naaber, P.; Maimets, M. (2012). Prolonged outbreak of Serratia marcescens in Tartu University hospital: a case-control study. BMC Infectious Diseases, 12 (1), 281.10.1186/1471-2334-12-281.
5.2.
2012
Naaber, P.; Sepp, E.; Pai, K.; LilĮo, J.; Pavelkovich, A.; Stsepetova, J .; Ivanova, M.; Lõįvukene, K.; Kõljalg, S. (2012). Molecular Epidemiology of Extended Spectrum Beta-Lactamases (ESBLs) in Estonia. BIT's 2nd Annual World Congress of Microbes-2012(WCM-2012), Guangzhou, China, July 30-August 1, 2012.
5.2.
2012
Kõljalg, S.; Naaber, P.; Rätsep, M.; Smidt, I.; Shkut, J.; Jaanimäe, L.; Löhr, L.H; ,Stsepetova, J.; Mändar, R.; Sepp, E. (2012). Population dynamics and sporulation of quinolone resistant and sensitive Clostridium difficile strains in different environmental conditions. 4th International Clostridium difficile Symposium; Bled, Slovenia, September 20-22, 2012.
1.1.
2011
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Jaanimäe, Liis; Löhr, Iren; Natås, Olav; Truusalu, Kai; Sepp, Epp (2011). Quantification of Clostridium difficile in Antibiotic-Associated Diarrhea Patients. Journal of Clinical Microbiology, 49 (10), 3656−3658.10.1128/JCM.05115-11.
1.1.
2011
Sepp, Epp; Stšepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Mändar, Reet; Jaanimäe, Liis; Löhr, IH; Natås, OB; Naaber, Paul (2011). Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe, 17, 407−409.
5.2.
2011
Kõljalg, S.; Stsepetova, J.; Smidt, I., Löhr, I; Truusalu, K.; Naaber, P.; Sepp, E. (2011). Antibiotic susceptibility, class I integrons and sporulation activity of Clostridium difficile strains from antibiotic-associated diarrhoea patients in two different years in Estonia and Norway. 21th ECCMID Milano, Italy 7-10 May 2011.
5.2.
2011
Naaber, P.; Smidt, I.; Rätsep, M.; Kõljalg, S.; Shkut, E.; Sepp, E. (2011). Strain-specific susceptibility of Clostridium difficile to inhibitory activity of Lactobacillus plantarum in vitro. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Kõljalg, S.; Rätsep, M.; Stsepetova, J.; Smidt, I.; Shkut, E.; Naaber, P.; Sepp, E. (2011). Sporulation level of Clostridium difficile integron positive and negative strains in the presence of lactobacilli. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Naaber, Paul; Jelena , Stsepetova; Imbi, Smidt; Elena, Shkut; Merele, Rätsep; Siiri, Kõljalg; krista, Lõivukene; Reet, Mändar; Iren, Löhr; Olav, Natas; Epp, Sepp (2011). Application of molecular methods for invetigation og intestinallactoflora and Clostridium difficile in antibiotic-associated diarrhea patients. 2nd ASMET-The ASM Emerging Technologies Conference: ASMET Conferences; San Juan, Pueto Rico; March 8-11, 2011. USA, 41−42.
1.1.
2010
Pähkla, E-R.; Jõgi, E.; Nurk, A.; Pisarev, H.; Koppel, T.; Naaber, P.; Saag, M.; Lõivukene, K. (2010). Periodontal disease in mothers indicates risk in their children. International Journal of Paediatric Dentistry, 20, 24−30.
1.2.
2010
Suitso, I.; Jõgi, E.; Talpsep, E.; Naaber, P.; Lõivukene, K.; Ots, M.-L.; Michelson, T.; Nurk, A. (2010). Protective effect by Bacillus smithii TBMI12 spores of Salmonella Enteritidis in mice. Beneficial Microbes, 37−42.
1.3.
2010
Lõivukene, Krista; Adamson, Vivika; Mitt, Piret; Kõljalg, Siiri; Sepp, Epp; Ivanova, Marina; Jürna-Ellam, Marika; Kirs, Kaisa; Nurk, Allan; Rõõm, Aino; Truusalu, Kai; Naaber, Paul (2010). Metitsilliiniresistentse Staphylococcus aureus’e osakaal, esmasavaldumus ja antibiootikumiresistentsus Eestis. Eesti Arst, 89 (10), 630−636.
3.4.
2010
Naaber, P. (2010). Clostridium difficile – fra toxinpåvisning til dyrkning. Hva bør laboratoriene gjøre? Hva bør de sende fra seg? Strategirapport: Strategimøte nr 23, 2009: Anaerob diagnostikk; Oslo. _EditorsAbbr Sandven, P; Steinbakk, M. Oslo, 66−70.
5.1.
2010
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Shkut, Elena; Rätsep, Merele; Kõljalg, Siiri; Lõivukene, Krista; Mänadar, Reet; Löhr, Irene; Natas, Borg; Sepp, Epp (2010). Intestinal Lactroflora in Patients with Antibiotic Associated Diarrhea (AAD). XXXIII Inernational Congress on Microbial Ecology and Diseases, Greece 6-10 September 2010. Greece, 22.
5.2.
2010
Smidt, I.; Sepp, E.; Rätsep, M.; Kõljalg, S.; Lõivukene, K.; Löhr, I.; Natas, O.; Mändar, R.; Naaber, P. (2010). Quantitative evaluation of Clostridium difficile and intestinal lactobacilli in patients with associated diarrhoea. Clinical Microbiology and Infection, 16: 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria 10-13 april 2010. , S575. (2).
5.2.
2010
Naaber, P.; Truusalu, K.; Smidt, I.; Kõljalg, S.; Sepp, E.; Hütt, P.; Mändar, R.; Mikelsaar, M. (2010). Protective effect of xylitol and lactobacilli against Clostridium difficile infection in hamster model. Clinical Microbiology and Infection, 16 : 20th ECCMID, Vienna, Austria 10-13 April 2010. (2).
5.2.
2010
Jaanimäe, Liis; Stsepetova, Jelena; Naaber, Paul; Sepp, Epp (2010). Seedetrakti laktofloora antibiootikumidega seotud diarröaga patsientidel. Eesti Arst, 9. , 599.
1.1.
2009
Hanberger, H.; Arman, D.; Gill, H.; Jindrák, V.; Kalenic, S.; Kurcz, A.; Licker, M.; Naaber, P.; Scicluna, E.A.; Vanis, V.; Walther, S.M. (2009). Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Medicine, 35 (1), 91−100. DOI: 10.1007/s00134-008-1237-y.
1.1.
2009
Sepp, E.; Stsepetova, J.; Lõivukene, K.; Truusalu, K.; Kõljalg, S.; Naaber, P.; Mikelsaar, M. (2009). The occurrence of antimicrobial resistance and class 1 integrons among commensal Escherichia coli isolates from infants and elderly persons. Annals of Clinical Microbiology and Antimicrobials, 8 (34), 1−6.
1.1.
2009
Naaber, Paul; Makoid, Ene; Aus, Anneli; Lõivukene, Krista; Põder, Airi (2009). Evaluation of ID–PaGIA syphilis antibody test. Indian Journal of Dermatology, Leprology and Venerology, 75 (5), 492−494.
1.1.
2009
Mitt, P.; Adamson, V.; Lõivukene, K.; Lang, K.; Telling, K.; Päro, K.; Rõõm, A.; Naaber, P.; Maimets, M. (2009). Epidemiology of nosocomial bloodstream infections in Estonia. Journal of Hospital Infection, 71, 365−370.
5.2.
2009
Lõivukene, K; Adamson, V; Ivanova, M; Jürna-Ellam, M; Kirs, K; Kõljalg, S; Mitt, P; Nurk, A; Rõõm, A; Sepp, E;i Truusalu, K; Naaber, P. (2009). Incidence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus isolates in Estonia.
5.2.
2009
Sepp, E.; Kõjalg, S.; Stsepetova, J., Smidt, I.; Rätsep, M.; Jaanimäe, L.; Naaber, P. (2009). Quantitative evaluation of lactobacilli and Clostridium difficile in faeces of patients with antibiotic associated diarrhoea and antibiotic resistance isolated strains. Fostering Cross-disciplinary Applied Research in Microbiology and Microbial Biotechnology: III International Conference on Environmental, Industrial and Applied Microbiology, BioMicroWorld 2009; Lisboa, Portugal; 2.-4.12.2009. , 543.
5.2.
2009
Löhr, I.; Jaanimäe, L.; Kindingstad, L.; Kõljalg, S.; Natas, O.; Sepp, E.; Smidt, I.; Štšepetova, J.; Wornaes, J.; Naaber, P. (2009). Clostridium difficile resistance and ribitypes in Norway and Estonia. Clostridia: The Impact of Genomics on Disease Control: 6th ClostPath International Conference; Rome, Italy; 19.-23.10.2009. , 75.
5.2.
2009
Pähkla, E.-R.; Naaber, P.; Lõivukene, K. (2009). Diagnosis and antibiotic treatment of chronic periodontitis in the southern Estonia. Journal of Clinical Periodontology, 36: Europerio 6; Stockholm, Sweden;4-6 juuni 2009. Blackwell Munksgaard, 155−156. (9).
1.1.
2008
Truusalu, K.; Mikelsaar, R-H.; Naaber, P.; Karki, T.; Kullisaar, T.; Zilmer, M.; Mikelsaar, M. (2008). Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiology, 8 (132), 1−6. DOI: 10.1186/1471-2180-8-132.
1.2.
2008
Jõgi, E.; Nurk, A.; Suitso, I.; Talpsep, E.; Naaber, P.; Lõivukene, K. (2008). Bacillus Smithii Strain TBMI12 MSCL P737 and Use of Endospores thereof as a Probiotic or a Food Supplement. World Intellectual Property Organization International Bureau bulletin, 1.
1.3.
2008
Pähkla, E-R.; Koppel, T.; Saag, M.; Naaber, P.; Treumuth, M.; Sepp, E.; Lõivukene, K. (2008). Kroonilise parodontiidi diagnostika ja antibiootikumiravi Lõuna-Eestis. Eesti Arst, 87 (11), 841−846.
1.3.
2008
Lõivukene, K.; Pähkla, E-R.; Koppel, T.; Kõljalg, S.; Kermes, K.; Allik, M.; Juhani, A.; Saag, M.; Adamson, V.; Mitt, P.; Sepp, E.; Truusalu, K.; Naaber, P. (2008). TÜ Kliinikumi ühendlaboris isoleeritud anaeroobide spekter ja ravimitundlikkus. Eesti Arst, 87 (11), 834−840.
5.2.
2008
Lõivukene, Krista; Kõljalg, Siiri; Kermes, Kadri; Allik, Merle; Juhani, Anneli; Adamson, Vivika; Telling, Kaidi; Ivanova, Marina; Naaber, Paul (2008). Fenotüübiliselt samastamiselt genotüübilisele: Mycobacterium fortuitum´i juhtum. Eesti Arst, 87: Arstiteaduskonna Teaduskonverents, Tartu 09.10 - 10.10.2008. OÜ Celsius Healthcare, 678. (9).
5.2.
2008
Michelson, T.; Suitso, I.; Talpsep, E.; Jõgi, E.; Naaber, P.; Nurk, A. (2008). A potential probiotic strain Bacillus smithii TBMI12 administrated as endospores and used as competitive exclusion agent against Salmonella enteritidis. International conference on the health impact and future pontential of benefical microbes: TNO Beneficial Microbes Conference; Amsterdam; the Netherlands; 29-30 May 2008.
5.2.
2008
Suitso, I.; Jõgi, E.; Talpsep, E.; Naaber, P.; Lõivukene, K.; Ots, M.-L.; Nurk, A. (2008). Competitive exclusion by Bacillus smithii TBMI12 spores of Salmonella Enteritidis in mice. NordForsk Advanced Lecture Course for PhD students, post docs and young scientists "Microorganisms and Health: Intestinal Bacteria, Probiotics and Pathogens"; Norway; 10-16 June 2008.
5.2.
2008
Truusalu, K.; Kõljalg, S.; Parm, Ü.; Sepp, E.; Metsvaht, T.; Naaber, P.; Lõivukene, K.; Lutsar, I. (2008). Staphylococcal Infection and Colonization of Pediatric Intensive Care Unit Patients: MRSA versus MRSE. Abstract book: Emerging Technologies of Medical Importance for the Diagnosis of Infectious Diseases and the Detection of Pathogenic Microbes. 1 st Intenational ASM Conference in Bejing, April 6-10, 2008. 44.
1.1.
2007
Tamm, E.; Naaber, P.; Maimets, M.; Oona, M.; Kõljalg, S.; Lutsar, I. (2007). Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999-2003. Clinical Microbiology and Infection, 13 (8), 824−826. DOI: 10.1111/j.1469-0691.2007.01743.x.
5.2.
2007
Truusalu, K.; Mikelsaar, R.-H.; Naaber, P.; Karki, T.; Kullisaar, T.; Zilmer, M.; Mikelsaar, M. (2007). Probiotic Lactobacillus Fermentum ME-3 ehances ofloxacin effect on Salmonelle Typhimurium infection in a murine model. Kliiniline toitumine (vene keeles), 1-2: Probiotics, Synbiotics and Functional Foods; Scientific and Clinical Aspects; May 15-16. St. Peterburg: Medlain-Medina, A16.
5.2.
2007
Mitt, P.; Adamson, V.; Lõivukene, K.; Lang, K.; Telling, K.; Päro, K.; Rõõm, A.; Naaber, P.; Maimets, M. (2007). Nosokomiaalsete vereringeinfektsioonide epidemioloogia Eestis. Eesti Arst, 86(6). Eesti Arst, 677−678.
1.1.
2006
Altraja, A.; Naaber, P.; Tamm, E.; Meriste, S.; Kullamaa, A.; Leesik, H. (2006). Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia. Journal of Antimicrobial Chemotherapy, 18 (6), 603−609.
1.1.
2006
Lõivukene, K.; Kermes, K.; Sepp, E.; Adamson, V.; Mitt, P.; Jürna, M.; Mägi, H.; Kallandi, Ü.; Otter, K.; Naaber, P. (2006). The comparison of susceptibility patterns of Gram-negative invasive and non-invasive pathogens in Estonian hospitals. Antonie van Leeuwenhoek, 89, 367−371.
1.1.
2006
Lõivukene, K.; Sepp, E.; Adamson, V.; Mitt, P.;Kallandi, Ü.; Otter, K.; Naaber, P. (2006). Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data. Scandinavian Journal of Infectious Diseases, 38, 1001−1008. DOI: 10.1080/00365540600786507.
1.2.
2006
Pähkla, E.-R.; Koppel, T.; Naaber, P.; Saag, M.; Lõivukene, K. (2006). The efficacy of non-surgical and systemic antibiotic treatment on smoking and non-smoking patients.(submitted). Stomatologija, 8 (4), 116−121.
1.2.
2006
Lõivukene, K.; Kermes, K.; Sepp, E.; Adamson, V.; Mitt, P.; Kallandi, U.; Otter, K.; Naaber, P. (2006). Surveillance of antimicrobial resistance of invasive pathogens: the Estonian experience. Eurosurveillance, 11 (2), 47−49.
1.3.
2006
Pähkla, E-R.; Lõivukene, K.; Koppel, T.; Naaber, P.; Saag, M. (2006). Suitsetamise mõju kroonilise parodontiidiga patsientide mittekirurgilise ja süsteemse antibiootilise ravikombinatsiooni efektiivsusele. Eesti Arst, 85 (1), 20−25.
5.1.
2006
Põder, A.; Naaber, P.; Brilene, T.; Hallen, A.; Domeika, M. (2006). Management of sexually transmitted infections in Estonia: results of Estonian-Swedish project. International journal of STD & AIDS, 17. Royal Soc Medicine Press Ltd, 138. (Suppl.1).
5.2.
2006
Mitt, P.; Lõivukene, K.; Adamson, V.; Kermes, K.; Laeneste, T.; Maimets, M.; Naaber, P. (2006). Bloodstream infections in an Estonian university hospital. 16th European Congress of Clinical Microbiology and Infectious Diseases; Nice, France; April 1-4, 2006.
1.1.
2005
Naaber, P.; Uuskula, A.; Naaber, J.; Poder, A.; Hjelm, E.; Hallen, A.; Unemo, M.; Domeika, M. (2005). Laboratory diagnosis of sexually transmitted infections in Estonia in 2001-2002: Shortcomings with impact on diagnostic quality and surveillance. Sexually Transmitted Diseases, 32 (12), 759−764.
1.2.
2005
Lõivukene, K.; Pähkla, E.; Koppel, T.; Saag, M.; Naaber, P. (2005). The Microbial Status of Patients with Periodontitis in Southern Estonia after Non-surgical Periodontal Therapy. Stomatologija, 7 (2), 45−47.
1.3.
2005
Lõivukene, K.; Kermes, K.; Sepp, E.; Adamson, V.; Mitt, P.; Kallandi, Ü.; Otter, K.; Pirožkova, L.; Kolesnikova, V.; Rõõm, A.; Kamõnina, N.; Timmas, T.; Kirs, K.; Voiko, R.; Nemtseva, G.; Mägi, H.; Jürna, M.; Päro, K.; Laaring, Ü.; Abel, K. ... Naaber, P. (2005). Invasiivsete patogeenide struktuur ja antibiootikumitundlikkus: olukord Eestis 2004. Eesti Arst, 84 (8), 520−526.
5.2.
2005
Mikelsaar, M.; Truusalu, K.; Kullisaar, T.; Naaber, P.; Mikelsaar, R.-H.; Zilmer, M. (2005). Effect of probiotic induced antioxidative response in experimental murine typhoid. XI International Congress of Bacteriology and Applied Microbiology; California, USA; July 2005.
1.1.
2004
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2004). Screening of toenail onychomycosis in Estonia. Mycoses, 47, 57−61.
1.1.
2004
Järv, H.; Lehtmaa, J.; Summerbell, R.C.; Hoekstra, E.S.; Samson, R.A.; Naaber, P. (2004). Neosartorya pseudofischeri isolated from blood – first hint of pulmonary aspergillosis. Journal of Clinical Microbiology, 42 (2), 925−928.
1.1.
2004
Naaber, P.; Mikelsaar, M. (2004). Interactions between lactobacilli and antibiotic-associated diarrhea. Advances in Applied Microbiology, 54, 231−260.
1.1.
2004
Naaber, P.; Smidt, I.; Stsepetova, J.; Brilene, T.; Annuk, H.; Mikelsaar, M. (2004). Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. Journal of Medical Microbiology, 53 (6), 551−554.
1.3.
2004
Lõivukene, K.; Sepp, E.; Adamson, V.; Kallandi, Ü.; Otter, K.; Mägi, H.; Parts, A.; Rõõm, A.; Naaber, P. (2004). Acinetobacter baumannii, Pseudomonas aeruginosa ja Klebsiella pneumoniae tähtsus ja antibiootikumitundlikkus Eesti haiglate intensiivravi osakondades. Eesti Arst, 83 (8), 526−534.
5.2.
2004
Lõivukene, K.; Sepp, E.; Adamson, V.; Kallandi, Ü.; Otter, K.; Naaber, P. (2004). Gram-negative nosocomial pathogens in Estonian intensive care units. Clinical Microbiology Inf, 10 S3: 14th European Congress of Clinical Microbiology and Infectious Diseases; Prague, Chech Republic; 1-4.05.2004. P504.
1.1.
2003
Loivukene, K.; Naaber, P. (2003). Antibiotic susceptibility of clinically relevant anerobes in Estonia from 1999 to 2001. Anaerobe, 9 (2), 57−61.
1.3.
2003
Lõivukene, K.; Pähkla, E-R.; Koppel, T.; Saag, M.; Naaber, P. (2003). Parodontiidi esmase ravi efektiivsuse mikrobioloogiline hindamine ja patogeenide spekter. Eesti Arst, 82 (11), 768−772.
1.1.
2002
Koljalg, S.; Naaber, P.; Mikelsaar, M. (2002). Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. Journal of Hospital Infection, 51 (2), 106−113.
1.1.
2000
Naaber, P.; Koljalg, S.; Maimets, M. (2000). Antibiotic usage and resistance - trends in Estonian University Hospitals. International Journal of Antimicrobial Agents, 16 (3), 309−315.
1.1.
2000
Naaber, P.; Smidt, I.; Tamme, K.; Liigant, A.; Tapfer, H.; Mikelsaar, M.; Talvik, R. (2000). Translocation of indigenous microflora in an experimental model of sepsis. Journal of Medical Microbiology, 49 (5), 431−439.
1.1.
2000
Naaber, P.; Tamm, E.; Putsepp, A.; Koljalg, S.; Maimets, M. (2000). Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clinical Microbiology and Infection, 6 (12), 675−677.
1.1.
1999
Bjorksten, B.; Naaber, P.; Sepp, E.; Mikelsaar, M. (1999). The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clinical and Experimental Allergy, 29 (3), 342−346.
1.1.
1998
Naaber, P.; Mikelsaar, RH.; Salminen, S.; Mikelsaar, M. (1998). Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. Journal of Medical Microbiology, 47 (7), 591−598.
4.2.
1998
Mikelsaar, M.; Mändar, R.(Toim.) (1998). Kliinilise mikrobioloogia käsiraamat. Tallinn: Medicina.
1.1.
1997
Sepp, E.; Julge, K.; Vasar, M.; Naaber, P.; Bjorksten, B.; Mikelsaar, M. (1997). Intestinal microflora of Estonian and Swedish infants. Acta Paediatrica, 86 (9), 956−961.
1.1.
1997
Naaber, P.; Klaus, K.; Sepp, E.; Bjorksten, B.; Mikelsaar, M. (1997). Colonization of infants and hospitalized patients with Clostridium difficile and lactobacilli. Clinical Infectious Diseases, 25, S189−S190.
1.1.
1997
Naaber, P.; Maimets, M.; Mikelsaar, M. (1997). Prevalence and properties of Clostridium difficile in hospitalized patients of Estonia. Reviews in Medical Microbiology, 8, S60−S61.
1.1.
1996
Naaber, P.; Lehto, E.; Salminen, S.; Mikelsaar, M. (1996). Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunology and Medical Microbiology, 14 (4), 205−209.
30.11.2020

Paul Naaber

https://www.etis.ee/CV/Paul_Naaber/eng
7.12.1966
paul.naaber@ut.ee

Career

Institutions and positions
01.01.2021–...   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Associate Professor in Medical Microbiology (0,25)
01.01.2013–...   
SYNLAB Eesti OÜ, Head of Infectious Disease Diagnostics (1,00)
01.10.2020–31.12.2020   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Senior Research Fellow in Medical Microbiology (0,25)
01.10.2019–30.09.2020   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Senior Research Fellow in Medical Microbiology (0,35)
01.01.2018–30.09.2019   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Senior Research Fellow in Medical Microbiology (0,10)
01.01.2016–31.12.2017   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Senior Research Fellow in Medical Microbiology (0,10)
01.01.2015–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Microbiology, Senior Research Fellow in Medical Microbiology (0,50)
01.12.2011–31.12.2014   
University of Tartu, Faculty of Medicine, Department of Microbiology, Senior Research Fellow in Medical Microbiology (0,50)
01.01.2010–30.11.2011   
University of Tartu, Faculty of Medicine, Department of Microbiology, Senior Research Fellow in Medical Microbiology (0,20)
01.12.2007–31.12.2009   
University of Tartu, Faculty of Medicine, Department of Microbiology, Senior Research Fellow (0,20)
01.01.2006–31.12.2012   
Stavanger University Hospitals, Microbiology Consultant
01.01.2005–30.11.2007   
University of Tartu, Faculty of Medicine, Department of Microbiology, Senior Research Fellow (0,30)
01.01.2005–31.12.2005   
Other staff
01.01.2001–31.12.2004   
Tartu University Clinics, Director of United Laboratories
1998–2006   
Tartu University Hospital, Head of Department (1,00)
01.01.1998–31.12.2005   
Tartu University, senior researcher
01.01.1996–31.12.1998   
Assistant, Dept Microbiology, University of Tartu
01.01.1996–31.12.1997   
Senior Technician, Dept Microbiology, University of Tartu
01.01.1995–31.12.1998   
Berner Eesti AS, Product Manager
01.01.1992–31.12.1997   
Clinical Microbiologist, Dept Clinical Microbiology, United Laboratories of Tartu University Clinics
01.01.1991–31.12.1992   
University of tartu, Dept Infectious Diseases
 
 
Education
1999–2001   
University of Tartu (Open University), Faculty of Philosophy (basic and medium grade in philosophy)
1998–2000   
University of Tartu, post-doc training
1992–1997   
University of Tartu, Ph.D. training in microbiology and infectious diseases (1992-1997). Doctor of medical sciences 1997
1985–1991   
University of Tartu, Medical faculty
1982–1985   
Tallinna 2. Secondary school

Qualifications

Academic degrees
Paul Naaber, Doctor's Degree, 1997, (sup) Marika Mikelsaar; Matti Maimets, Clostridium difficile infection and intestinal microbial ecology, University of Tartu, Faculty of Medicine.
 
 
Fields of research
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.2. Microbiology; CERCS CLASSIFICATION: B230 Microbiology, bacteriology, virology, mycology ; SPECIFICATION: Clinical Microbiology, Antimicrobial Resistance, Microbial Ecology
 
 

Projects in progress

Completed projects

Supervised dissertations

Publications

Category
Year
Publication
 
1.1.
2020
Naaber, Paul; Hunt, Kaidi; Pesukova, Jaana; Haljasmägi, Liis; Rumm, Pauliina; Peterson, Pärt; Hololejenko, Jelena; Eero, Irina; Jõgi, Piia; Toompere, Karolin; Sepp, Epp (2020). Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. PLoS ONE, 15 (10), e0237548. DOI: 10.1371/journal.pone.0237548.
5.2.
2020
Piia Jõgi1,2, Diana Ingerainen3, Mari Soots4, Freddy Lättekivi5,6,7, Paul Naaber8,9, Karolin Toompere10, Hannes Vaas1, Pärt Peterson11, Katrin Kaarna6,7, Heli Paluste12, Kai Kisand11, Marje Oona13, Riina Janno6,7, Irja Lutsar8 (2020). Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1). ESCMID Conference on Coronavirus Disease (ECCVID), virtual 23-25.09.2020. ESCMID.
6.8.
2020
Veerus, Piret; Salumets, Andres; Naaber, Paul; Krjutškov, Kaarel; Tilk, Kadi; Laanpere, Made; Uusküla, Anneli (2020). Seroprevalence of SARS-CoV-2 antibodies among pregnant women in Estonia: A call for epidemiological studies. Acta Obstetricia Et Gynecologica Scandinavica, 1736−1737. DOI: 10.1111/aogs.13995.
1.1.
2019
Bilozor, Anastasia; Balode, Arta; Chakhunashvili, Giorgi; Chumachenko, Tetyana; Egorova, Svetlana; Ivanova, Marina; Kaftyreva, Liidia; Kõljalg, Siiri; Kõressaar, Triinu; Lysenko, Olga; Miciuleviciene, Jolanta; Mändar, Reet; Lis, Danuta O.; Wesolowska, Monika Pomorska; Ratnik, Kaspar; Remm, Maido; Rudzko, Jelena; Rööp, Tiiu; Saule, Mara; Sepp, Epp ... Naaber, Paul (2019). Application of Molecular Methods for Carbapenemase Detection. Frontiers in Microbiology, 10, ARTN 1755. DOI: 10.3389/fmicb.2019.01755.
1.1.
2019
Sepp, Epp; Andreson, Reidar; Balode, Arta; Bilozor, Anastasia; Brauer, Age; Egorova, Svetlana; Huik, Kristi; Ivanova, Marina; Kaftyreva, Lidia; Kõljalg, Siiri; Koressaar, Triinu; Makarova, Maria; Miciuleviciene, Jolanta; Pai, Kristiine; Remm, Maido; Rööp, Tiiu; Naaber, Paul (2019). Phenotypic and Molecular Epidemiology of ESBL-, AmpC-, and Carbapenemase-Producing Escherichia coli in Northern and Eastern Europe. Frontiers in Microbiology, 10, ARTN 2465. DOI: 10.3389/fmicb.2019.02465.
1.3.
2019
Mikelsaar, Marika; Lõivukene, Krista; Naaber, Paul; Mändar, Reet (2019). Helicobacter pyllori infektsioonide teaduspõhine diagnostika ja mikroobivastane ravi [Evidence based diagnostics and antimicrobial treatment of Helicobacter pylori infections]. Eesti Arst, 98 (7), 381−384.
5.2.
2018
Naaber, Paul; Rudzko, Jelena; Pavelkovich, Anastasia; Ivanova, Marina; Sepp, Epp; Ratnik, Kaspar; Kõljalg, Siiri; Rööp, Tiiu; Remm, Maido; Kaftyreva, Liidia; Egorova, Svetlana; Miciuleviciene, Jolanta; Balode, Arta; Saule, Marta; Tsereteli, David; Chakhunashvili, Giorgi; Titiv, Leonid; Shyshporonok, Julia; Lysenko, Olga; Chumachenko, Tatyana ... Wesolowska, Monika (2018). Comparison of Coris rapid test with other methods for carbapenemases detectiotion in Klebsiella pneumoniae. In: (60).35h annual meeting NSCMID, Reykjavik 19-22 august. Reykjavik, Island.
1.1.
2017
Roosaare, Märt; Vaher, Mihkel; Kaplinski, Lauris; Möls, Märt; Andreson, Reidar; Lepamets, Maarja; Kõressaar, Triinu; Naaber, Paul; Kõljalg, Siiri; Remm, Maido (2017). StrainSeeker: fast identification of bacterial strains from raw sequencing reads using user-provided guide trees. PeerJ, 5, ARTN e3353−e3353.10.7717/peerj.3353.
1.1.
2017
Rätsep M.; Kõljalg S.; Sepp E.; Smidt I.; Truusalu K.; Songisepp E.; Stsepetova J.; Naaber P.; Mikelsaar R.H.; Mikelsaar M. (2017). A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection. Anaerobe, 47, 94−103.10.1016/j.anaerobe.2017.03.019.
5.2.
2016
Pavelkovich, A.; Naaber, P.; Ivanova, M.; Sepp, E.; Rööp, T.; Plaas, K.; Kaftyreva, L.; Egorova, S.; Miciuleviciene, J.; Balode, A.; Saule, M.; Tsereteli, D.; Chakhunashvili, G.; Lysenko, O.; Chumachenko, T.; Wesolowska, M.; Lis, D.; Titov, L.; Shyshporonok, J. (2016).

Karbapeneemiresistentsuse uurimine Enterobacteriaceae, Pseudomonas aeruginosa ja Acinetobacter spp. tüvedel 9 Euroopa riigis

. Eesti Arst, 95 (lisa 2): Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2016; Tartu; 13.-14.10.2016. Celsius Healthcare OÜ, 33−33.
5.2.
2016
Pavelkovich, A.; Ivanova, M.; Kõljalg, S.; Naaber, P.; Pai, K.; Sepp, E.; BEEp research team (2016). Epidemiology of AB resistant gram-negative bacteria in the Baltic Sea region. Eesti Arst, 95 (Supplement1): XIII Baltic Congress in Laboratory Medicine; Tartu, Estonia; May 12-14 2016. OÜ Celsius Healthcare, 39.
1.3.
2015
Ivanova, M.; Pavelkovich, A.; Naaber, P. (2015). Ida-Tallinna Keskhaigla mikrobioloogia labori rahvusvaheline koostöö. Eesti Arst, 94 (4), 9−11.
1.1.
2014
Pavelkovich, Anastasia; Balode, Arta; Edquist, Petra; Egorova, Svetlana; Ivanova, Marina; Kaftyreva, Lidia; Konovalenko, Irina; Kõljalg, Siiri; Lillo, Jana; Lipskaya, Lidia; Miciuleviciene, Jolanta; Pai, Kristiine; Parv, Kristel; Pärna, Katri; Rööp, Tiiu; Sepp, Epp; Štšepetova, Jelena; Naaber, Paul (2014). Detection of Carbapenemase-Producing Enterobacteriaceae in the Baltic Countries and St. Petersburg Area. BioMed Research International, 2014, Article 548960.10.1155/2014/548960.
1.1.
2014
Mitt, P.; Metsvaht, T.; Adamson, V.; Telling, K..; Naaber, P.; Lutsar, I.; Maimets , M. (2014). Five-year prospective surveillance of nosocomial bloodstream infections in an Estonian paediatric intensive care unit. Journal of Hospital Infection, 86 (2), 95−99.10.1016/j.jhin.2013.11.002.
1.3.
2013
Егорова, СА; Кафтыреща, ЛА; Липская, ЛВ; Коноваленко, ИБ; Пясетская, МФ; Курчикова, ТС; Ведерникова, НБ; Морозова, ОТ; Смирнова, МБ; Попенко, ЛН; Любушкина, МИ; Савочкина, ЮА; Макарова, МА; Сужаева, ЛВ; Останкова, ЮВ; Иванова, МН; Павелкович, АМ; Наабер, П; Сепп, Э; Кыльялг, С ... Балоде, А. (2013). Штаммы энтеробактерий, продуцирующие бета-лактамазы пасширенного спектра и металло-В-лактамазу НДМ-1, выделенные в стационарах в странах Балтийского региона. Инфекция и иммунитет, 3 (1), 29−36.
5.2.
2013
Rätsep, Merle; Naaber, Paul; Kõljalg, Siiri; Smidt, Imbi; Shkut, Leena; Sepp, Epp (2013). Antagonistic activity of culture supernatant of lactobacilli against the growth of Clostridium difficile in vitro. ClostPath 2013 Meeting; Palm Cove, Australia; 22.-26. October 2013.
5.2.
2013
Pavelkovich, A; Balode, A; Edquist, P; Egorova, S; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Lipskaya, L; Miciuleviciene, J; Pai, K; Sepp, E; Sparbier, K; Naaber, P (2013). Detection of carbapenem-non-susceptible Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013..
5.2.
2013
Lillo, J; Balode, A; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Makarova, M; Miciuleviciene, J; Naaber, P; Pai, K; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). Differences in virulence factors of Escherichia coli isolated from the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Naaber, P; Balode, A; Djundika, T; Egorova, S; Huik, K; Kaftyreva, L; Kamõnina, N; Kirs, K; Kõljalg, S; Konovalenko, I; Kurchikova, T; Lillo, J; Lipskaya, L; Lõivukene, L; Makarova, M; Makstutis, G; Miciuleviciene, J; Morozova, O; Pai, K; Parv, K ... Ivanova, M (2013). Epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Pai, K; Balode, B; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Miciuleviciene, J; Naaber, P; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). The molecular epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
1.1.
2012
Adamson, V.; Mitt, P.; Pisarev, H.; Metsvaht, T.; Telling, K.; Naaber, P.; Maimets, M. (2012). Prolonged outbreak of Serratia marcescens in Tartu University hospital: a case-control study. BMC Infectious Diseases, 12 (1), 281.10.1186/1471-2334-12-281.
5.2.
2012
Naaber, P.; Sepp, E.; Pai, K.; LilĮo, J.; Pavelkovich, A.; Stsepetova, J .; Ivanova, M.; Lõįvukene, K.; Kõljalg, S. (2012). Molecular Epidemiology of Extended Spectrum Beta-Lactamases (ESBLs) in Estonia. BIT's 2nd Annual World Congress of Microbes-2012(WCM-2012), Guangzhou, China, July 30-August 1, 2012.
5.2.
2012
Kõljalg, S.; Naaber, P.; Rätsep, M.; Smidt, I.; Shkut, J.; Jaanimäe, L.; Löhr, L.H; ,Stsepetova, J.; Mändar, R.; Sepp, E. (2012). Population dynamics and sporulation of quinolone resistant and sensitive Clostridium difficile strains in different environmental conditions. 4th International Clostridium difficile Symposium; Bled, Slovenia, September 20-22, 2012.
1.1.
2011
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Jaanimäe, Liis; Löhr, Iren; Natås, Olav; Truusalu, Kai; Sepp, Epp (2011). Quantification of Clostridium difficile in Antibiotic-Associated Diarrhea Patients. Journal of Clinical Microbiology, 49 (10), 3656−3658.10.1128/JCM.05115-11.
1.1.
2011
Sepp, Epp; Stšepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Mändar, Reet; Jaanimäe, Liis; Löhr, IH; Natås, OB; Naaber, Paul (2011). Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe, 17, 407−409.
5.2.
2011
Kõljalg, S.; Stsepetova, J.; Smidt, I., Löhr, I; Truusalu, K.; Naaber, P.; Sepp, E. (2011). Antibiotic susceptibility, class I integrons and sporulation activity of Clostridium difficile strains from antibiotic-associated diarrhoea patients in two different years in Estonia and Norway. 21th ECCMID Milano, Italy 7-10 May 2011.
5.2.
2011
Naaber, P.; Smidt, I.; Rätsep, M.; Kõljalg, S.; Shkut, E.; Sepp, E. (2011). Strain-specific susceptibility of Clostridium difficile to inhibitory activity of Lactobacillus plantarum in vitro. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Kõljalg, S.; Rätsep, M.; Stsepetova, J.; Smidt, I.; Shkut, E.; Naaber, P.; Sepp, E. (2011). Sporulation level of Clostridium difficile integron positive and negative strains in the presence of lactobacilli. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Naaber, Paul; Jelena , Stsepetova; Imbi, Smidt; Elena, Shkut; Merele, Rätsep; Siiri, Kõljalg; krista, Lõivukene; Reet, Mändar; Iren, Löhr; Olav, Natas; Epp, Sepp (2011). Application of molecular methods for invetigation og intestinallactoflora and Clostridium difficile in antibiotic-associated diarrhea patients. 2nd ASMET-The ASM Emerging Technologies Conference: ASMET Conferences; San Juan, Pueto Rico; March 8-11, 2011. USA, 41−42.
1.1.
2010
Pähkla, E-R.; Jõgi, E.; Nurk, A.; Pisarev, H.; Koppel, T.; Naaber, P.; Saag, M.; Lõivukene, K. (2010). Periodontal disease in mothers indicates risk in their children. International Journal of Paediatric Dentistry, 20, 24−30.
1.2.
2010
Suitso, I.; Jõgi, E.; Talpsep, E.; Naaber, P.; Lõivukene, K.; Ots, M.-L.; Michelson, T.; Nurk, A. (2010). Protective effect by Bacillus smithii TBMI12 spores of Salmonella Enteritidis in mice. Beneficial Microbes, 37−42.
1.3.
2010
Lõivukene, Krista; Adamson, Vivika; Mitt, Piret; Kõljalg, Siiri; Sepp, Epp; Ivanova, Marina; Jürna-Ellam, Marika; Kirs, Kaisa; Nurk, Allan; Rõõm, Aino; Truusalu, Kai; Naaber, Paul (2010). Metitsilliiniresistentse Staphylococcus aureus’e osakaal, esmasavaldumus ja antibiootikumiresistentsus Eestis. Eesti Arst, 89 (10), 630−636.
3.4.
2010
Naaber, P. (2010). Clostridium difficile – fra toxinpåvisning til dyrkning. Hva bør laboratoriene gjøre? Hva bør de sende fra seg? Strategirapport: Strategimøte nr 23, 2009: Anaerob diagnostikk; Oslo. _EditorsAbbr Sandven, P; Steinbakk, M. Oslo, 66−70.
5.1.
2010
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Shkut, Elena; Rätsep, Merele; Kõljalg, Siiri; Lõivukene, Krista; Mänadar, Reet; Löhr, Irene; Natas, Borg; Sepp, Epp (2010). Intestinal Lactroflora in Patients with Antibiotic Associated Diarrhea (AAD). XXXIII Inernational Congress on Microbial Ecology and Diseases, Greece 6-10 September 2010. Greece, 22.
5.2.
2010
Smidt, I.; Sepp, E.; Rätsep, M.; Kõljalg, S.; Lõivukene, K.; Löhr, I.; Natas, O.; Mändar, R.; Naaber, P. (2010). Quantitative evaluation of Clostridium difficile and intestinal lactobacilli in patients with associated diarrhoea. Clinical Microbiology and Infection, 16: 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria 10-13 april 2010. , S575. (2).
5.2.
2010
Naaber, P.; Truusalu, K.; Smidt, I.; Kõljalg, S.; Sepp, E.; Hütt, P.; Mändar, R.; Mikelsaar, M. (2010). Protective effect of xylitol and lactobacilli against Clostridium difficile infection in hamster model. Clinical Microbiology and Infection, 16 : 20th ECCMID, Vienna, Austria 10-13 April 2010. (2).
5.2.
2010
Jaanimäe, Liis; Stsepetova, Jelena; Naaber, Paul; Sepp, Epp (2010). Seedetrakti laktofloora antibiootikumidega seotud diarröaga patsientidel. Eesti Arst, 9. , 599.
1.1.
2009
Hanberger, H.; Arman, D.; Gill, H.; Jindrák, V.; Kalenic, S.; Kurcz, A.; Licker, M.; Naaber, P.; Scicluna, E.A.; Vanis, V.; Walther, S.M. (2009). Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Medicine, 35 (1), 91−100. DOI: 10.1007/s00134-008-1237-y.
1.1.
2009
Sepp, E.; Stsepetova, J.; Lõivukene, K.; Truusalu, K.; Kõljalg, S.; Naaber, P.; Mikelsaar, M. (2009). The occurrence of antimicrobial resistance and class 1 integrons among commensal Escherichia coli isolates from infants and elderly persons. Annals of Clinical Microbiology and Antimicrobials, 8 (34), 1−6.
1.1.
2009
Naaber, Paul; Makoid, Ene; Aus, Anneli; Lõivukene, Krista; Põder, Airi (2009). Evaluation of ID–PaGIA syphilis antibody test. Indian Journal of Dermatology, Leprology and Venerology, 75 (5), 492−494.
1.1.
2009
Mitt, P.; Adamson, V.; Lõivukene, K.; Lang, K.; Telling, K.; Päro, K.; Rõõm, A.; Naaber, P.; Maimets, M. (2009). Epidemiology of nosocomial bloodstream infections in Estonia. Journal of Hospital Infection, 71, 365−370.
5.2.
2009
Lõivukene, K; Adamson, V; Ivanova, M; Jürna-Ellam, M; Kirs, K; Kõljalg, S; Mitt, P; Nurk, A; Rõõm, A; Sepp, E;i Truusalu, K; Naaber, P. (2009). Incidence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus isolates in Estonia.
5.2.
2009
Sepp, E.; Kõjalg, S.; Stsepetova, J., Smidt, I.; Rätsep, M.; Jaanimäe, L.; Naaber, P. (2009). Quantitative evaluation of lactobacilli and Clostridium difficile in faeces of patients with antibiotic associated diarrhoea and antibiotic resistance isolated strains. Fostering Cross-disciplinary Applied Research in Microbiology and Microbial Biotechnology: III International Conference on Environmental, Industrial and Applied Microbiology, BioMicroWorld 2009; Lisboa, Portugal; 2.-4.12.2009. , 543.
5.2.
2009
Löhr, I.; Jaanimäe, L.; Kindingstad, L.; Kõljalg, S.; Natas, O.; Sepp, E.; Smidt, I.; Štšepetova, J.; Wornaes, J.; Naaber, P. (2009). Clostridium difficile resistance and ribitypes in Norway and Estonia. Clostridia: The Impact of Genomics on Disease Control: 6th ClostPath International Conference; Rome, Italy; 19.-23.10.2009. , 75.
5.2.
2009
Pähkla, E.-R.; Naaber, P.; Lõivukene, K. (2009). Diagnosis and antibiotic treatment of chronic periodontitis in the southern Estonia. Journal of Clinical Periodontology, 36: Europerio 6; Stockholm, Sweden;4-6 juuni 2009. Blackwell Munksgaard, 155−156. (9).
1.1.
2008
Truusalu, K.; Mikelsaar, R-H.; Naaber, P.; Karki, T.; Kullisaar, T.; Zilmer, M.; Mikelsaar, M. (2008). Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiology, 8 (132), 1−6. DOI: 10.1186/1471-2180-8-132.
1.2.
2008
Jõgi, E.; Nurk, A.; Suitso, I.; Talpsep, E.; Naaber, P.; Lõivukene, K. (2008). Bacillus Smithii Strain TBMI12 MSCL P737 and Use of Endospores thereof as a Probiotic or a Food Supplement. World Intellectual Property Organization International Bureau bulletin, 1.
1.3.
2008
Pähkla, E-R.; Koppel, T.; Saag, M.; Naaber, P.; Treumuth, M.; Sepp, E.; Lõivukene, K. (2008). Kroonilise parodontiidi diagnostika ja antibiootikumiravi Lõuna-Eestis. Eesti Arst, 87 (11), 841−846.
1.3.
2008
Lõivukene, K.; Pähkla, E-R.; Koppel, T.; Kõljalg, S.; Kermes, K.; Allik, M.; Juhani, A.; Saag, M.; Adamson, V.; Mitt, P.; Sepp, E.; Truusalu, K.; Naaber, P. (2008). TÜ Kliinikumi ühendlaboris isoleeritud anaeroobide spekter ja ravimitundlikkus [The spectrum and antibiotic susceptibility of anaerobic bacteria isolated in Tartu University Hospital]. Eesti Arst, 87 (11), 834−840.
5.2.
2008
Lõivukene, Krista; Kõljalg, Siiri; Kermes, Kadri; Allik, Merle; Juhani, Anneli; Adamson, Vivika; Telling, Kaidi; Ivanova, Marina; Naaber, Paul (2008). Fenotüübiliselt samastamiselt genotüübilisele: Mycobacterium fortuitum´i juhtum. Eesti Arst, 87: Arstiteaduskonna Teaduskonverents, Tartu 09.10 - 10.10.2008. OÜ Celsius Healthcare, 678. (9).
5.2.
2008
Michelson, T.; Suitso, I.; Talpsep, E.; Jõgi, E.; Naaber, P.; Nurk, A. (2008). A potential probiotic strain Bacillus smithii TBMI12 administrated as endospores and used as competitive exclusion agent against Salmonella enteritidis. International conference on the health impact and future pontential of benefical microbes: TNO Beneficial Microbes Conference; Amsterdam; the Netherlands; 29-30 May 2008.
5.2.
2008
Suitso, I.; Jõgi, E.; Talpsep, E.; Naaber, P.; Lõivukene, K.; Ots, M.-L.; Nurk, A. (2008). Competitive exclusion by Bacillus smithii TBMI12 spores of Salmonella Enteritidis in mice. NordForsk Advanced Lecture Course for PhD students, post docs and young scientists "Microorganisms and Health: Intestinal Bacteria, Probiotics and Pathogens"; Norway; 10-16 June 2008.
5.2.
2008
Truusalu, K.; Kõljalg, S.; Parm, Ü.; Sepp, E.; Metsvaht, T.; Naaber, P.; Lõivukene, K.; Lutsar, I. (2008). Staphylococcal Infection and Colonization of Pediatric Intensive Care Unit Patients: MRSA versus MRSE. Abstract book: Emerging Technologies of Medical Importance for the Diagnosis of Infectious Diseases and the Detection of Pathogenic Microbes. 1 st Intenational ASM Conference in Bejing, April 6-10, 2008. 44.
1.1.
2007
Tamm, E.; Naaber, P.; Maimets, M.; Oona, M.; Kõljalg, S.; Lutsar, I. (2007). Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999-2003. Clinical Microbiology and Infection, 13 (8), 824−826. DOI: 10.1111/j.1469-0691.2007.01743.x.
5.2.
2007
Truusalu, K.; Mikelsaar, R.-H.; Naaber, P.; Karki, T.; Kullisaar, T.; Zilmer, M.; Mikelsaar, M. (2007). Probiotic Lactobacillus Fermentum ME-3 ehances ofloxacin effect on Salmonelle Typhimurium infection in a murine model. Kliiniline toitumine (vene keeles), 1-2: Probiotics, Synbiotics and Functional Foods; Scientific and Clinical Aspects; May 15-16. St. Peterburg: Medlain-Medina, A16.
5.2.
2007
Mitt, P.; Adamson, V.; Lõivukene, K.; Lang, K.; Telling, K.; Päro, K.; Rõõm, A.; Naaber, P.; Maimets, M. (2007). Nosokomiaalsete vereringeinfektsioonide epidemioloogia Eestis. Eesti Arst, 86(6). Eesti Arst, 677−678.
1.1.
2006
Altraja, A.; Naaber, P.; Tamm, E.; Meriste, S.; Kullamaa, A.; Leesik, H. (2006). Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia. Journal of Antimicrobial Chemotherapy, 18 (6), 603−609.
1.1.
2006
Lõivukene, K.; Kermes, K.; Sepp, E.; Adamson, V.; Mitt, P.; Jürna, M.; Mägi, H.; Kallandi, Ü.; Otter, K.; Naaber, P. (2006). The comparison of susceptibility patterns of Gram-negative invasive and non-invasive pathogens in Estonian hospitals. Antonie van Leeuwenhoek, 89, 367−371.
1.1.
2006
Lõivukene, K.; Sepp, E.; Adamson, V.; Mitt, P.;Kallandi, Ü.; Otter, K.; Naaber, P. (2006). Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data. Scandinavian Journal of Infectious Diseases, 38, 1001−1008. DOI: 10.1080/00365540600786507.
1.2.
2006
Pähkla, E.-R.; Koppel, T.; Naaber, P.; Saag, M.; Lõivukene, K. (2006). The efficacy of non-surgical and systemic antibiotic treatment on smoking and non-smoking patients.(submitted). Stomatologija, 8 (4), 116−121.
1.2.
2006
Lõivukene, K.; Kermes, K.; Sepp, E.; Adamson, V.; Mitt, P.; Kallandi, U.; Otter, K.; Naaber, P. (2006). Surveillance of antimicrobial resistance of invasive pathogens: the Estonian experience. Eurosurveillance, 11 (2), 47−49.
1.3.
2006
Pähkla, E-R.; Lõivukene, K.; Koppel, T.; Naaber, P.; Saag, M. (2006). Suitsetamise mõju kroonilise parodontiidiga patsientide mittekirurgilise ja süsteemse antibiootilise ravikombinatsiooni efektiivsusele. Eesti Arst, 85 (1), 20−25.
5.1.
2006
Põder, A.; Naaber, P.; Brilene, T.; Hallen, A.; Domeika, M. (2006). Management of sexually transmitted infections in Estonia: results of Estonian-Swedish project. International journal of STD & AIDS, 17. Royal Soc Medicine Press Ltd, 138. (Suppl.1).
5.2.
2006
Mitt, P.; Lõivukene, K.; Adamson, V.; Kermes, K.; Laeneste, T.; Maimets, M.; Naaber, P. (2006). Bloodstream infections in an Estonian university hospital. 16th European Congress of Clinical Microbiology and Infectious Diseases; Nice, France; April 1-4, 2006.
1.1.
2005
Naaber, P.; Uuskula, A.; Naaber, J.; Poder, A.; Hjelm, E.; Hallen, A.; Unemo, M.; Domeika, M. (2005). Laboratory diagnosis of sexually transmitted infections in Estonia in 2001-2002: Shortcomings with impact on diagnostic quality and surveillance. Sexually Transmitted Diseases, 32 (12), 759−764.
1.2.
2005
Lõivukene, K.; Pähkla, E.; Koppel, T.; Saag, M.; Naaber, P. (2005). The Microbial Status of Patients with Periodontitis in Southern Estonia after Non-surgical Periodontal Therapy. Stomatologija, 7 (2), 45−47.
1.3.
2005
Lõivukene, K.; Kermes, K.; Sepp, E.; Adamson, V.; Mitt, P.; Kallandi, Ü.; Otter, K.; Pirožkova, L.; Kolesnikova, V.; Rõõm, A.; Kamõnina, N.; Timmas, T.; Kirs, K.; Voiko, R.; Nemtseva, G.; Mägi, H.; Jürna, M.; Päro, K.; Laaring, Ü.; Abel, K. ... Naaber, P. (2005). Invasiivsete patogeenide struktuur ja antibiootikumitundlikkus: olukord Eestis 2004. Eesti Arst, 84 (8), 520−526.
5.2.
2005
Mikelsaar, M.; Truusalu, K.; Kullisaar, T.; Naaber, P.; Mikelsaar, R.-H.; Zilmer, M. (2005). Effect of probiotic induced antioxidative response in experimental murine typhoid. XI International Congress of Bacteriology and Applied Microbiology; California, USA; July 2005.
1.1.
2004
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2004). Screening of toenail onychomycosis in Estonia. Mycoses, 47, 57−61.
1.1.
2004
Järv, H.; Lehtmaa, J.; Summerbell, R.C.; Hoekstra, E.S.; Samson, R.A.; Naaber, P. (2004). Neosartorya pseudofischeri isolated from blood – first hint of pulmonary aspergillosis. Journal of Clinical Microbiology, 42 (2), 925−928.
1.1.
2004
Naaber, P.; Mikelsaar, M. (2004). Interactions between lactobacilli and antibiotic-associated diarrhea. Advances in Applied Microbiology, 54, 231−260.
1.1.
2004
Naaber, P.; Smidt, I.; Stsepetova, J.; Brilene, T.; Annuk, H.; Mikelsaar, M. (2004). Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. Journal of Medical Microbiology, 53 (6), 551−554.
1.3.
2004
Lõivukene, K.; Sepp, E.; Adamson, V.; Kallandi, Ü.; Otter, K.; Mägi, H.; Parts, A.; Rõõm, A.; Naaber, P. (2004). Acinetobacter baumannii, Pseudomonas aeruginosa ja Klebsiella pneumoniae tähtsus ja antibiootikumitundlikkus Eesti haiglate intensiivravi osakondades. Eesti Arst, 83 (8), 526−534.
5.2.
2004
Lõivukene, K.; Sepp, E.; Adamson, V.; Kallandi, Ü.; Otter, K.; Naaber, P. (2004). Gram-negative nosocomial pathogens in Estonian intensive care units. Clinical Microbiology Inf, 10 S3: 14th European Congress of Clinical Microbiology and Infectious Diseases; Prague, Chech Republic; 1-4.05.2004. P504.
1.1.
2003
Loivukene, K.; Naaber, P. (2003). Antibiotic susceptibility of clinically relevant anerobes in Estonia from 1999 to 2001. Anaerobe, 9 (2), 57−61.
1.3.
2003
Lõivukene, K.; Pähkla, E-R.; Koppel, T.; Saag, M.; Naaber, P. (2003). Parodontiidi esmase ravi efektiivsuse mikrobioloogiline hindamine ja patogeenide spekter. Eesti Arst, 82 (11), 768−772.
1.1.
2002
Koljalg, S.; Naaber, P.; Mikelsaar, M. (2002). Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. Journal of Hospital Infection, 51 (2), 106−113.
1.1.
2000
Naaber, P.; Koljalg, S.; Maimets, M. (2000). Antibiotic usage and resistance - trends in Estonian University Hospitals. International Journal of Antimicrobial Agents, 16 (3), 309−315.
1.1.
2000
Naaber, P.; Smidt, I.; Tamme, K.; Liigant, A.; Tapfer, H.; Mikelsaar, M.; Talvik, R. (2000). Translocation of indigenous microflora in an experimental model of sepsis. Journal of Medical Microbiology, 49 (5), 431−439.
1.1.
2000
Naaber, P.; Tamm, E.; Putsepp, A.; Koljalg, S.; Maimets, M. (2000). Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clinical Microbiology and Infection, 6 (12), 675−677.
1.1.
1999
Bjorksten, B.; Naaber, P.; Sepp, E.; Mikelsaar, M. (1999). The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clinical and Experimental Allergy, 29 (3), 342−346.
1.1.
1998
Naaber, P.; Mikelsaar, RH.; Salminen, S.; Mikelsaar, M. (1998). Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. Journal of Medical Microbiology, 47 (7), 591−598.
4.2.
1998
Mikelsaar, M.; Mändar, R.(Toim.) (1998). Kliinilise mikrobioloogia käsiraamat. Tallinn: Medicina.
1.1.
1997
Sepp, E.; Julge, K.; Vasar, M.; Naaber, P.; Bjorksten, B.; Mikelsaar, M. (1997). Intestinal microflora of Estonian and Swedish infants. Acta Paediatrica, 86 (9), 956−961.
1.1.
1997
Naaber, P.; Klaus, K.; Sepp, E.; Bjorksten, B.; Mikelsaar, M. (1997). Colonization of infants and hospitalized patients with Clostridium difficile and lactobacilli. Clinical Infectious Diseases, 25, S189−S190.
1.1.
1997
Naaber, P.; Maimets, M.; Mikelsaar, M. (1997). Prevalence and properties of Clostridium difficile in hospitalized patients of Estonia. Reviews in Medical Microbiology, 8, S60−S61.
1.1.
1996
Naaber, P.; Lehto, E.; Salminen, S.; Mikelsaar, M. (1996). Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunology and Medical Microbiology, 14 (4), 205−209.
30.11.2020

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Lihtotsing Tühjenda
  • Leitud 12 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
RITA1AlamprojektLMVBS19497 (RITA1/02-75-02)Antibiootikumiresistentsuse levikuteed ja resistentsuse ohjamise võimalused01.07.201930.06.2022Irja LutsarTartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut158 015,00 EUR
ETFETF5826Antibiootikumresistentsete enterobakterite levik Eestis ja resistentsust põhjustavate integronide olemasolu enterobakteritel 01.01.200431.12.2006Epp SeppTartu Ülikool, Arstiteaduskond18 541,89 EUR
1.1.5.2.1.31.SARMB11183T (3.2.0701.11-0013)Antibiootikumresistentsuse molekulaarne multipleks diagnostika01.11.201131.12.2014Siiri KõljalgTartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut575 233,00 EUR
EMPEMP13Clostridium difficile infektsioon Eestis ja Norras: molekulaarepidemioloogia (k.a. hüpervirulentse tüve 027 esinemine), tüvede omadused ja seedtreakti laktobatsillide koosmõju 01.04.200831.03.2010Epp SeppTartu Ülikool, Arstiteaduskond54 760,98 EUR
ETFETF7933Clostridium difficile tüvede resistentsus antibiootikumide ja desinfektantide suhtes olenevalt nende feno- ja genotüüpilistest omadustest01.01.200931.12.2011Siiri KõljalgTartu Ülikool, Arstiteaduskond44 175,68 EUR
SFSF0182555s03Inimese mikroobiökoloogia ja selle mõjutamisvõimalused olulisemate Eestis levinud krooniliste haiguste patogeneesis01.01.200331.12.2007Marika MikelsaarTartu Ülikool, Arstiteaduskond331 190,17 EUR
IUTIUT34-19Inimese mikroobiökoloogiliste häirete mõjustamine erinevate terviseseisundite korral01.01.201531.12.2020Reet MändarTartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut624 558,00 EUR
ETFETF7649Metitsilliiniresistentse Staphylococcus aureus`e (MRSA) molekulaarne epidemioloogia Eestis01.01.200831.12.2010Krista LõivukeneSA Tartu Ülikooli Kliinikum, Tartu Ülikooli Klliinikumi ühendlabor45 072,67 EUR
SFSF0180132s08Mikrofloora tasakaaluhäire kui krooniliste põletike riskifaktor ja selle korrigeerimisvõimalused01.01.200831.12.2013Reet MändarTartu Ülikool, Arstiteaduskond802 264,57 EUR
MUUSLOMR12214T (3.2.0701.12-0047)Mitte-invasiivsete biomarkerite arendamine reproduduktiivtervise ja rasedustüsistuste molekaardiagnostikas01.09.201231.08.2015Maris LaanTartu Ülikool711 888,30 EUR
ETFETF6458Nosokominaalsete vereringeinfektsioonide epidemioloogia ning invasiivsete baktertüvede antibiootikumresistentsuse geneetilised markerid01.01.200531.12.2008Matti MaimetsTartu Ülikool, Arstiteaduskond74 791,65 EUR
ETFETF9059Uuemate beeta-laktamaaside epidemioloogia Balti regioonis ja võimalused nende reaalajas molekulaarseke skriininguks01.01.201231.12.2015Epp SeppTartu Ülikool, Arstiteaduskond72 000,00 EUR